The epigenetic medicine company anchors its Peninsula headquarters as the Bay Area life sciences market navigates a gradual recovery. Epicrispr Biotechnologies, the CRISPR-pioneer-founded epigenetic medicine company known commercially as Epic Bio, renewed its 24,780-square-foot lease at 7000 Shoreline Court in South San Francisco during the first quarter of 2026, according to CBRE's Q1 2026 San […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
The University of California's investment office has taken over the Ritz-Carlton Half...
ByThe RegistryNovember 6, 2026Stanford Health Care has renewed its 35,000-square-foot lease at 867 American Street...
ByThe RegistryNovember 6, 2026Uris Acquisitions, the Union Square buying vehicle of Ian Jacobs and Max...
ByThe RegistryNovember 6, 2026Seven months after cutting nearly half its workforce, payments company Block has...
ByThe RegistryNovember 6, 2026